jump to content jump to footer

Customizable reading templates for therapy response assessment

mint Lesion offers customizable reading templates for therapy response assessment in clinical care and research. Adapt parameters, define lesion categories, and evaluate responses. Track key measurements like diameter, volume, SUV, and ADC, ensuring compliance with required minimum sizes. Automate sum calculations for response determination and integrate clinical data such as ctDNA or PSA values. Document multiple lesions, compare absolute and relative changes over time, and visualize trends with interactive charts. Generate comprehensive reports with tables and graphs for a clear longitudinal overview.

Key features:

  • Easily customizable parameters
    • Questions for manual response evaluation
    • Lesion categories (e.g., target lesions, non-target lesions)
    • System-derived lesion states (e.g., normalized for lymph nodes)
    • Key measurement values (e.g., longest diameter, short axis, volume, SUV, ADC, etc.), including required minimum size for each lesion category
    • Sum of measurements for response determination (e.g., sum of diameter or sum of volume)
    • Clinical data (e.g., ctDNA or PSA values)
  • Ability to document the count of multiple (non-target and new) lesions
  • Automatic calculations of absolute and relative differences to baseline, previous timepoint and nadir
  • Interactive charts displaying all relevant values over time, including clinical data, with dynamic filtering options
  • Comprehensive reports including tables and graphs for a fast and clear longitudinal overview
A collaborative session between a radiologist and an investigator analyzing multicentric trial progress and quantitative imaging data on a centralized dashboard.
Integrated Data Management for Multicentric Imaging in Investigator-Initiated Trials (IITs)
Establishing a Framework for Multicentric Data Coordination For many investigators, the transition from a single-site study to a multicentric model…
Read more
mint Lesion usage during a clinical trial read, featuring the TGRM export tool.
Bridging the Gap Between RECIST and Survival: Why the FDA’s Analysis of the g Value is a Game-Changer
For decades, oncology trials have relied on RECIST 1.1 to evaluate drug efficacy. However, these categorical "snapshot" evaluations do not always…
Read more
Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.
The two-day “RECIST and Beyond” workshop at radCIO Cologne offered intensive hands-on training on RECIST, iRECIST, mRECIST and LI-RADS, with real-case reporting performed directly in mint Lesion.
Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging
How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?
Read more
scroll-top